BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 27470709)

  • 21. Rapid Fire: Acute Blast Crisis/Hyperviscosity Syndrome.
    Emerson G; Kaide CG
    Emerg Med Clin North Am; 2018 Aug; 36(3):603-608. PubMed ID: 30037446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study.
    Vergez F; Green AS; Tamburini J; Sarry JE; Gaillard B; Cornillet-Lefebvre P; Pannetier M; Neyret A; Chapuis N; Ifrah N; Dreyfus F; Manenti S; Demur C; Delabesse E; Lacombe C; Mayeux P; Bouscary D; Recher C; Bardet V
    Haematologica; 2011 Dec; 96(12):1792-8. PubMed ID: 21933861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Time to Clearance of Peripheral Blood Blasts Predicts Complete Remission and Survival in Chinese Adults with Acute Myeloid Leukemia.
    Li X; Zhu H; Zhang Y; Zhao W; Mi J; Hu J; Li J
    Acta Haematol; 2016; 135(4):217-23. PubMed ID: 26967450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukapheresis Does Not Improve Early Survival Outcome of Acute Myeloid Leukemia with Leukostasis Patients - A Dual-Center Retrospective Cohort Study.
    Rinaldi I; Sari RM; Tedhy VU; Winston K
    J Blood Med; 2021; 12():623-633. PubMed ID: 34290537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?
    Bewersdorf JP; Zeidan AM
    Cells; 2020 Oct; 9(10):. PubMed ID: 33080779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of the time from diagnosis to induction therapy on prognosis in patients with acute leukemia undergoing leukapheresis for symptomatic hyperleukocytosis.
    Pınar İE; Özkocaman V; Ersal T; Dağtekin ME; Yalçın C; Orhan B; Candar Ö; Çubukçu S; Güllü Koca T; Gürsoy V; Özkalemkaş F
    Ther Apher Dial; 2023 Aug; 27(4):802-812. PubMed ID: 37039816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits.
    Shallis RM; Stahl M; Bewersdorf JP; Hendrickson JE; Zeidan AM
    Expert Rev Hematol; 2020 May; 13(5):489-499. PubMed ID: 32248712
    [No Abstract]   [Full Text] [Related]  

  • 28. Peripheral blood blast clearance is an independent prognostic factor for survival and response to acute myeloid leukemia induction chemotherapy.
    Short NJ; Benton CB; Chen HC; Qiu P; Gu L; Pierce S; Brandt M; Maiti A; Min TL; Naqvi K; Quintas-Cardama A; Konopleva M; Kadia T; Cortes J; Garcia-Manero G; Ravandi F; Jabbour E; Kantarjian H; Andreeff M
    Am J Hematol; 2016 Dec; 91(12):1221-1226. PubMed ID: 27474808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exchange Transfusion and Leukapheresis in Pediatric Patients with AML With High Risk of Early Death by Bleeding and Leukostasis.
    Creutzig U; Rössig C; Dworzak M; Stary J; von Stackelberg A; Wössmann W; Zimmermann M; Reinhardt D
    Pediatr Blood Cancer; 2016 Apr; 63(4):640-5. PubMed ID: 26670831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A rare complication of leukostasis with AML M4 patient: Microcirculatory dysfunction of upper extremities.
    Ersayoğlu İ; Yazıcı Özkaya P; Metin H; Hekimci H; Zararcı K; Yılmaz Karapınar D; Karapınar B
    Transfus Apher Sci; 2023 Aug; 62(4):103717. PubMed ID: 37173209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: feasibility, toxicity, and therapeutic results.
    Ferrara F; Izzo T; Criscuolo C; Riccardi C; Celentano M; Mele G
    Am J Hematol; 2010 Sep; 85(9):687-90. PubMed ID: 20652967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of therapeutic leukapheresis in hyperleukocytotic AML.
    Pastore F; Pastore A; Wittmann G; Hiddemann W; Spiekermann K
    PLoS One; 2014; 9(4):e95062. PubMed ID: 24733550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High dose cyclophosphamide for cytoreduction in patients with acute myeloid leukemia with hyperleukocytosis or leukostasis.
    Zhao J; Bewersdorf JP; Jaszczur S; Kowalski A; Perreault S; Schiffer M; Gore S; Podoltsev N; Prebet T; Shallis R; Zeidan AM
    Leuk Lymphoma; 2021 May; 62(5):1195-1202. PubMed ID: 33325761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis.
    Inaba H; Fan Y; Pounds S; Geiger TL; Rubnitz JE; Ribeiro RC; Pui CH; Razzouk BI
    Cancer; 2008 Aug; 113(3):522-9. PubMed ID: 18484648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic leukapheresis for hyperleukocytosis in acute myelocytic leukemia.
    Cuttner J; Holland JF; Norton L; Ambinder E; Button G; Meyer RJ
    Med Pediatr Oncol; 1983; 11(2):76-8. PubMed ID: 6572782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial respiratory status in hyperleukocytic acute myeloid leukemia: prognostic significance and effect of leukapheresis.
    Van de Louw A; Schneider CW; Desai RJ; Claxton DF
    Leuk Lymphoma; 2016; 57(6):1319-26. PubMed ID: 26374497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic leukapheresis in patients with leukostasis secondary to acute myelogenous leukemia.
    De Santis GC; de Oliveira LC; Romano LG; Almeida Prado Bde P; Simoes BP; Rego EM; Covas DT; Falcao RP
    J Clin Apher; 2011; 26(4):181-5. PubMed ID: 21574176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of early mortality between leukapheresis and non-leukapheresis in adult acute myeloid leukemia patients with hyperleukocytosis: a systematic review and meta-analysis.
    Rinaldi I; Sutandyo N; Winston K
    Hematology; 2022 Dec; 27(1):141-149. PubMed ID: 35068391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT.
    Canaani J; Labopin M; Socié G; Nihtinen A; Huynh A; Cornelissen J; Deconinck E; Gedde-Dahl T; Forcade E; Chevallier P; Bourhis JH; Blaise D; Mohty M; Nagler A
    Am J Hematol; 2017 Jul; 92(7):653-659. PubMed ID: 28370339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: no impact on early mortality and intracranial hemorrhage.
    Chang MC; Chen TY; Tang JL; Lan YJ; Chao TY; Chiu CF; Ho HT
    Am J Hematol; 2007 Nov; 82(11):976-80. PubMed ID: 17636473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.